CERC - European Cardiovascular Research Center
Founded by a group of physicians, CERC has a wide experience in clinical research. Their renown and expertise in this field have enabled them to generate optimal interaction with their industrial partners and other medical research teams focusing on the development of innovative techniques, concepts and treatments.
They provide unparalleled guidance and expert support in a broad range of clinical trials dedicated to the assessment of interventional coronary and peripheral revascularisation, structural and valvular heart disease treatments and adjunctive pharmacology.
Its objectives are to underpin European clinical trials and academic leadership, act as a global CRO and support young scientific leaders.
The CERC’s industrial partners attach great importance to finding cost-effective models which do not compromise quality.
Learn more: www.cerc-europe.org
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
September 18, 2025
September 25 – 11am – 12:30pm CEST •The meeting will start at 11.00AM o’clock.•Audio is available either through your computer or through phone connection (dial-in).•Your line will be kept on mute.•At the end, there will be time for questions and you can submit your questionsthrough the ‘question’ box.•After the webinar, connect to the EUCROF eLearnIN […]
September 18, 2025
September 23 – Namur, Belgium – Booths 26–27 Welcome to BioWin Day ! The premiere venue for doing business with Belgian health professionals, innovators and industry leaders. Explore new partnerships, see what’s evolving in biopharma and health-tech, and get a clear view of how a country as small as Belgium produces world-changing healthcare solutions. What […]
September 18, 2025
Biopharm International The bio/pharmaceutical industry is undergoing a significant digital shift, with artificial intelligence (AI) playing an increasingly vital role in achieving operational excellence and bolstering quality maturity. A strategic and well-governed approach to AI adoption is not merely an advantage but a necessity for enhancing efficiency while maintaining rigorous good practices (GxP) compliance, said […]